Carol H. Wysham

Endocrinology

400 E 5th Ave
Spokane, WA 99202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.

Journal: The lancet. Diabetes & endocrinology

Published: August 08, 2025

Preparing to Meet the Needs of a Growing Older Adult Population with Type 1 Diabetes: A Narrative Review.

Preparing to Meet the Needs of a Growing Older Adult Population with Type 1 Diabetes: A Narrative Review.

Journal: Journal of general internal medicine

Published: May 26, 2025

Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Single-Arm, Treat-to-Target Clinical Trial.

Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Single-Arm, Treat-to-Target Clinical Trial.

Journal: Diabetes technology & therapeutics

Published: March 05, 2025

A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus.

A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus.

Journal: Diabetes, obesity & metabolism

Published: November 22, 2024

Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.

Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: September 13, 2024

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.

Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment.

Journal: The New England journal of medicine

Published: September 10, 2024

Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.

Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.

Journal: Diabetes technology & therapeutics

Published: May 17, 2024

Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.

Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.

Journal: Diabetes, obesity & metabolism

Published: February 07, 2024

Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records.

Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records.

Journal: JMIR formative research

Published: May 23, 2023

The Impact of Web-Based Continuing Medical Education Using Patient Simulation on Real-World Treatment Selection in Type 2 Diabetes: Retrospective Case-Control Analysis.

The Impact of Web-Based Continuing Medical Education Using Patient Simulation on Real-World Treatment Selection in Type 2 Diabetes: Retrospective Case-Control Analysis.

Journal: JMIR medical education

Published: April 28, 2023

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.

Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.

Journal: Diabetes, obesity & metabolism

Published: May 19, 2022

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

Journal: Cardiovascular diabetology

Published: March 08, 2022

Showing 1-12 of 59

Last Updated: 09/26/2026